计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R304642-1mg |
1mg |
期货 ![]() |
| |
| R304642-5mg |
5mg |
期货 ![]() |
| |
| R304642-10mg |
10mg |
期货 ![]() |
| |
| R304642-25mg |
25mg |
期货 ![]() |
| |
| R304642-50mg |
50mg |
期货 ![]() |
|
| 别名 | 洛司普托 |
|---|---|
| 英文别名 | ROSIPTOR [WHO-DD] | CYCLOHEXANEMETHANOL, 2-((3AS,4R,5S,7AS)-4-(AMINOMETHYL)OCTAHYDRO-7A-METHYL-1-METHYLENE-1H-INDEN-5-YL)-5-HYDROXY-2-METHYL-, (1S,2R,5S)- | D11275 | MDEJTPWQNNMAQF-BVMLLJBZSA-N | DB13012 | ROSIPTOR [INN] | AC-30923 | Rosiptor (USAN/INN) | |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Rosiptor |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 激活剂 |
| 作用机制 | 磷脂酰肌醇-3,4,5-三磷酸 5-磷酸酶 1 激活剂 |
| 产品介绍 |
Rosiptor (AQX-1125) 是一种选择性的磷酸酶 SHIP1 激活剂,具有抗炎作用。Rosiptor (AQX-1125) 在体外抑制 Akt 磷酸化、炎症介质生成和白细胞趋化。 |
| 纯度 | ≥98% |
| ALogP | 3 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | (1S,3S,4R)-4-[(3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methylidene-3,3a,4,5,6,7-hexahydro-2H-inden-5-yl]-3-(hydroxymethyl)-4-methylcyclohexan-1-ol |
| INCHI | 1S/C20H35NO2/c1-13-4-5-17-16(11-21)18(7-9-19(13,17)2)20(3)8-6-15(23)10-14(20)12-22/h14-18,22-23H,1,4-12,21H2,2-3H3/t14-,15+,16+,17+,18+,19-,20+/m1/s1 |
| InChi Key | MDEJTPWQNNMAQF-BVMLLJBZSA-N |
| Smiles | C[C@@]1(CC[C@@H](C[C@@H]1CO)O)[C@H]2CC[C@]3([C@H]([C@@H]2CN)CCC3=C)C |
| Isomeric SMILES | C[C@@]1(CC[C@@H](C[C@@H]1CO)O)[C@H]2CC[C@]3([C@H]([C@@H]2CN)CCC3=C)C |
| PubChem CID | 76965484 |
| 分子量 | 321.5 |
| 分子量 | 321.500 g/mol |
|---|---|
| XLogP3 | 3.000 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 321.267 Da |
| 单同位素质量Monoisotopic Mass | 321.267 Da |
| 拓扑极表面积Topological Polar Surface Area | 66.500 Ų |
| 重原子数Heavy Atom Count | 23 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 465.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 7 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Stenton GR, Mackenzie LF, Tam P, Cross JL, Harwig C, Raymond J, Toews J, Wu J, Ogden N, MacRury T et al.. (2013) Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.. Br J Pharmacol, 168 (6): (1506-18). [PMID:23121445] |
| 2. Nickel JC, Egerdie B, Davis E, Evans R, Mackenzie L, Shrewsbury SB. (2016) A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.. J Urol, 196 (3): (747-54). [PMID:26968644] |
| 3. Li Gao, Junsheng Zhang, Tingting Yang, Ling Jiang, Xueqi Liu, Sheng Wang, Xian Wang, Yuebo Huang, Huaying Wang, Mengya Zhang, Tingting Gong, Lijuan Ma, Chao Li, Chaoyong He, Xiao-ming Meng, Yonggui Wu. (2023) STING/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease. MOLECULAR THERAPY, [PMID:37533255] [10.1016/j.ymthe.2023.07.026] |
| 4. Fangyuan Chen, Qingmei Liu, Lei Ma, Cuishi Yan, Haiman Zhang, Zhi Zhou, Wei Yi. (2024) Identification of Novel Organo-Se BTSA-Based Derivatives as Potent, Reversible, and Selective PPARγ Covalent Modulators for Antidiabetic Drug Discovery. JOURNAL OF MEDICINAL CHEMISTRY, 68 (1): (819-831). [PMID:39705161] [10.1021/acs.jmedchem.4c02803] |